The pharmaceutical exports in Poland experienced fluctuations over the past decade. From a value of $3.1 billion in 2013, exports peaked at $4.31 billion in 2017 but settled at $3.67 billion in 2023. Year-on-year variations show notable growth spurts, particularly in 2014 and 2017, with considerable drops in 2021 and slight declines towards 2023. The five-year CAGR for 2023 stands at -0.62%, indicating a slight contraction. Projections for 2028 foresee a continued gradual decline with a forecasted five-year CAGR of -1.37%.

Future trends to watch for:

Potential growth opportunities from emerging markets.
Impact of technological advancements on production and exports.
Regulatory changes within Poland and the EU.
Shifts in global demand for pharmaceutical products due to health crises or demographic changes.